Although experts agree that diet and lifestyle are the keys to preventing and reversing diabetes, the ballooning number of diabetics and pre-diabetics (estimated at over 10% and 1/3 of our population respectively) is too big a market for drug companies to ignore. With one toxic drug after another, they’re trying to convince the public that blood sugar regulation is a problem pills can solve. However an all-natural alternative approach is both safe and effective. Introduced last year, canagliflozin (Invokana) is the first in a new family of diabetes drugs called sodium glucose co-transporter 2 (SGLT2) inhibitors to be approved by the FDA. However, consumer advocate group Public Citizen has put it on their “do NOT use” drug list as having minimal benefit and dangerous side effects. Nonetheless, Forbes predicts it will reach $416 billion in sales by 2016. Although Invokana lowers blood sugar somewhat, it does so by doing what drugs always do—interfering with normal…